Provided by Tiger Trade Technology Pte. Ltd.

Cyber Hornet S&P 500 and Bitcoin 75/25 Strategy ETF

31.46
+0.11150.36%
Volume:202
Turnover:6.35K
Market Cap:7.87M
PE:-1.05K
High:31.46
Open:31.46
Low:31.46
Close:31.35
52wk High:32.01
52wk Low:24.95
Shares:250.00K
Float Shares:250.00K
Volume Ratio:0.08
T/O Rate:0.08%
Dividend:0.05
Dividend Rate:0.15%
EPS(TTM):-0.0300
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

GlobeNewswire
·
Apr 04

BBB Foods Files 2025 Form 20‑F, Strengthening Disclosure After NYSE Listing

TIPRANKS
·
Apr 03

CARE reaffirms Sanstar Limited’s BBB+ and A2 credit ratings

TIPRANKS
·
Apr 03

Ripple CEO Reacts to BBB Rating for Ripple Prime, Lists Three Points It Validates

utoday
·
Apr 02

CARE assigns BBB+; Stable rating to Finkurve Financial’s NCDs and bank facilities

TIPRANKS
·
Mar 31

S&P Downgrades Zhongsheng Group Holdings to BBB

MT Newswires Live
·
Mar 30

S&P Affirms SK Innovation at BBB- on Complex Impact of Middle East Conflict

MT Newswires Live
·
Mar 26

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

GlobeNewswire
·
Mar 25

Equinix Has A BBB+ Rating And A 51% Dividend Buffer. The CapEx Cycle Is The Variable Worth Watching.

Benzinga_recent_news
·
Mar 25

SRG Housing Finance Drops CARE Rating, Retains ACUITE BBB+

TIPRANKS
·
Mar 25

Nordic Credit Rating Assigns SalMar ASA BBB with Stable Outlook

TIPRANKS
·
Mar 20

EXCLUSIVE: Bitcoin ETFs Under Pressure — Cyber Hornet CEO Explains The Volatility Gap Between IBIT And BBB

Benzinga
·
Mar 20

S&P Downgrades Honda Motor to BBB+ on Electric Vehicle-Related Losses

MT Newswires Live
·
Mar 19

Scope affirms Elkem’s BBB- rating but assigns Negative Outlook

TIPRANKS
·
Mar 19

CARE reaffirms Godavari Biorefineries’ BBB+ rating amid sector headwinds

TIPRANKS
·
Mar 17

Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026

GlobeNewswire
·
Mar 17

S&P Downgrades Posco Holdings to BBB+ on Increased Capex, Weak Conditions

MT Newswires Live
·
Mar 17

Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target

TIPRANKS
·
Mar 17

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

GlobeNewswire
·
Mar 16

HMA Agro Industries Secures CRISIL BBB+ Rating for Rs 1,250 Crore Bank Facilities

TIPRANKS
·
Mar 14